Gel pillow designed specifically for obstructive sleep apnea treatment with continuous positive airway pressure / Travesseiro de gel com formato específico para o tratamento de apneia obstrutiva do sono com pressão positiva contínua nas vias aéreas

ABSTRACT Objective: To determine whether the use of a gel pillow with side cutouts designed to accommodate a continuous positive airway pressure (CPAP) mask and reduce head temperature improves the efficacy of and adherence to auto-CPAP therapy. Methods: Twenty-three consecutive CPAP-naïve patients with obstructive sleep apnea were enrolled in the study. Patients were given an auto-CPAP machine with an appropriate CPAP mask and were instructed to use CPAP for 15 nights. They were instructed to sleep with their own pillow (the control pillow) from nights 1 to 5 and with either a foam pillow or a gel pillow, both of which had side cutouts, for 5 consecutive nights each, in random order. After night 15, auto-CPAP machine data were downloaded and patients rated their satisfaction with each pillow on a visual analog scale. Results: Twenty-two patients completed the protocol. The pressures administered, residual apnea-hypopnea index, air leaks, and mean duration of CPAP use did not differ among the periods during which each pillow was used. Patients were significantly more satisfied with the gel pillow than with the control pillow and the foam pillow (p = 0.022 and p = 0.004, respectively), their level of satisfaction with the gel pillow correlating significantly with excessive daytime sleepiness (r2 = 0.19; p = 0.0443). Conclusions: Among obstructive sleep apnea patients treated with nasal CPAP, the use of a gel pillow with side cutouts appears to have no impact on treatment effectiveness. Nevertheless, such patients seem to prefer a gel pillow over other types of pillows.

RESUMO Objetivo: Determinar se o uso de um travesseiro de gel com recortes laterais para acomodar a máscara de continuous positive airway pressure (CPAP, pressão positiva contínua nas vias aéreas) e diminuir a temperatura em torno da cabeça melhora a eficácia do tratamento com auto-CPAP e a adesão dos pacientes ao tratamento. Métodos: Foram incluídos no estudo 23 pacientes consecutivos com apneia obstrutiva do sono que nunca haviam recebido tratamento com CPAP. Os pacientes receberam um aparelho de auto-CPAP com uma máscara apropriada e foram instruídos a usar CPAP durante 15 noites. Foram também instruídos a dormir com seu próprio travesseiro (o travesseiro controle) nas 5 primeiras noites e com um travesseiro de espuma ou um travesseiro de gel, ambos com recortes laterais, durante 5 noites consecutivas cada, em ordem aleatória. Depois da 15ª noite, os dados registrados nos aparelhos de auto-CPAP foram baixados e os pacientes determinaram seu grau de satisfação com cada travesseiro por meio de uma escala visual analógica. Resultados: Vinte e dois pacientes completaram o protocolo. Não houve diferenças entre os períodos durante os quais cada travesseiro foi usado quanto às pressões administradas, índice de apneia-hipopneia residual, vazamentos de ar e média de duração da CPAP. Os pacientes ficaram significativamente mais satisfeitos com o travesseiro de gel do que com o travesseiro controle e o travesseiro de espuma (p = 0,022 e p = 0,004, respectivamente), com correlação entre o grau de satisfação com o travesseiro de gel e a sonolência diurna excessiva (r2 = 0,19; p = 0,0443). Conclusões: Em pacientes com apneia obstrutiva do sono tratados com CPAP nasal, o uso de um travesseiro de gel com recortes laterais aparentemente não tem nenhum impacto na eficácia do tratamento. No entanto, esses pacientes aparentemente preferem um travesseiro de gel a outros tipos de travesseiros.

A negative expiratory pressure test during wakefulness for evaluating the risk of obstructive sleep apnea in patients referred for sleep studies

OBJECTIVE: Obstructive sleep apnea is characterized by increased upper airway collapsibility during sleep. The present study investigated the use of the negative expiratory pressure test as a method to rule out obstructive sleep apnea. METHODS: Flow limitation was evaluated in 155 subjects. All subjects underwent a diurnal negative expiratory pressure test and a nocturnal sleep study. The severity of sleep apnea was determined based on the apneahypopnea index. Flow limitation was assessed by computing the exhaled volume at 0.2, 0.5, and 1.0 s (V0.2, V0.5, and V1.0, respectively) during the application of a negative expiratory pressure and expressed as a percentage of the previous exhaled volume. Receiver-operating characteristic curves were constructed to identify the optimal threshold volume at 0.2, 0.5, and 1.0 s for obstructive sleep apnea detection. RESULTS: Mean expiratory volumes at 0.2 and 0.5 s were statistically higher (p <0.01) in healthy subjects than in all obstructive sleep apneic groups. Increasing disease severity was associated with lower expiratory volumes. The V0.2 ( percent) predictive parameters for the detection of sleep apnea were sensitivity (81.1 percent), specificity (93.1 percent), PPV (98.1 percent), and NPV (52.9 percent). Sensitivity and NPV were 96.9 percent and 93.2 percent, respectively, for moderate-to-severe obstructive sleep apnea, and both were 100 percent for severe obstructive sleep apnea. CONCLUSION: Flow limitation measurement by V 0.2 ( percent) during wakefulness may be a very reliable method to identify obstructive sleep apnea when the test is positive and could reliably exclude moderate and severe obstructive sleep apnea when the test is negative. The negative expiratory pressure test appears to be a useful screening test for suspected obstructive sleep apnea.

Upper airway collapsibility evaluated by a negative expiratory pressure test in severe obstructive sleep apnea

OBJECTIVES: To investigate the usefulness of measuring upper airway collapsibility with a negative expiratory pressure application as a screening test for severe obstructive sleep apnea (OSA). INTRODUCTION: OSA is a risk factor for cardiovascular disease, and it may have serious consequences. Its recognition may have important implications during the perioperative period. Increased upper airway collapsibility is one of the main determinants of OSA, and its evaluation could be useful for identifying this condition. METHODS: Severe OSA and normal subjects (24 in each group) were matched by body mass index and referred to our sleep laboratory. The subjects were enrolled in an overnight sleep study, and a diurnal negative expiratory pressure test was performed. Flow drop (DV) and expiratory volume were measured in the first 0.2 s (V02) of the negative expiratory pressure test. RESULTS: DV ( percent) and V02 ( percent) values were statistically different between normal and OSA subjects. OSA patients showed a greater decrease in flow than normal subjects. In addition, severely OSA patients exhaled during the first 0.2 s of the negative expiratory pressure application was an average of only 11.2 percent of the inspired volume compared to 34.2 percent for the normal subjects. Analysis of the receiver operating characteristics showed that V02 ( percent) and DV ( percent) could accurately identify severe OSA in subjects with sensitivities of 95.8 percent and 91.7 percent, respectively, and specificities of 95.8 percent and 91.7 percent, respectively. CONCLUSIONS: V02 ( percent) and DV ( percent) are highly accurate parameters for detecting severe OSA. The pharyngeal collapsibility measurement, which uses negative expiratory pressure during wakefulness, is predictive of collapsibility during sleep.